First Trust Advisors LP Purchases Shares of 688,017 agilon health, inc. (NYSE:AGL)

First Trust Advisors LP purchased a new stake in shares of agilon health, inc. (NYSE:AGL – Get Rating) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 688,017 shares of the company’s stock, valued at approximately $16,113,000. First Trust Advisors LP owned about 0.17% of agilon health at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Synovus Financial Corp increased its position in shares of agilon health by 5.1% during the third quarter. Synovus Financial Corp now owns 10,671 shares of the company’s stock valued at $251,000 after acquiring an additional 518 shares during the last quarter. Xponance Inc. boosted its stake in shares of agilon health by 3.8% in the third quarter. Xponance Inc. now owns 21,509 shares of the company’s stock valued at $504,000 after purchasing an additional 778 shares during the period. IFP Advisors Inc boosted its stake in shares of agilon health by 236.3% in the third quarter. IFP Advisors Inc now owns 1,231 shares of the company’s stock valued at $38,000 after purchasing an additional 865 shares during the period. Victory Capital Management Inc. boosted its stake in shares of agilon health by 4.1% in the third quarter. Victory Capital Management Inc. now owns 23,797 shares of the company’s stock valued at $557,000 after purchasing an additional 942 shares during the period. Finally, Utah Retirement Systems boosted its stake in shares of agilon health by 11.4% in the second quarter. Utah Retirement Systems now owns 9,800 shares of the company’s stock valued at $214,000 after purchasing an additional 1,000 shares during the period.

Wall Street Analyst Weigh In

AGL has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft raised their price objective on shares of agilon health from $26.00 to $28.00 in a research note on Friday, March 3rd. The Goldman Sachs Group lowered their price objective on shares of agilon health from $38.00 to $34.00 and set a “buy” rating for the company in a research note on Tuesday, November 15th. Guggenheim raised their price objective on shares of agilon health from $21.00 to $30.00 and gave the company a “buy” rating in a research note on Monday, March 6th. Wells Fargo & Company decreased their price target on shares of agilon health from $28.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, November 15th. Finally, Stifel Nicolaus began coverage on shares of agilon health in a research note on Thursday, December 8th. They issued a “buy” rating and a $23.00 price target for the company. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, agilon health currently has a consensus rating of “Moderate Buy” and a consensus price target of $28.63.

Insiders Place Their Bets

In other agilon health news, insider Benjamin Shaker sold 28,555 shares of the firm’s stock in a transaction that occurred on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now owns 25,625 shares of the company’s stock, valued at $598,856.25. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other agilon health news, insider Benjamin Shaker sold 28,555 shares of the firm’s stock in a transaction that occurred on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now owns 25,625 shares of the company’s stock, valued at $598,856.25. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Benjamin Kornitzer sold 2,698 shares of the firm’s stock in a transaction that occurred on Thursday, January 5th. The stock was sold at an average price of $15.51, for a total transaction of $41,845.98. Following the sale, the insider now directly owns 10,426 shares in the company, valued at approximately $161,707.26. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 70,864 shares of company stock valued at $1,515,177. 3.30% of the stock is owned by corporate insiders.

agilon health Stock Down 3.5 %

AGL stock opened at $22.84 on Friday. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.04. agilon health, inc. has a twelve month low of $14.82 and a twelve month high of $28.36. The company’s 50 day moving average is $21.10 and its two-hundred day moving average is $20.31. The stock has a market cap of $9.44 billion, a P/E ratio of -87.84 and a beta of 1.09.

agilon health Company Profile

(Get Rating)

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.